Nasdaq
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Palatin Technologies, Inc. develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the. treatment of premenopausal women with hypoactive sexual desire disorder.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | -$188,597.00 | $1.5M | $4.9M | $4.5M | $0.00 |
| Gross profit | — | — | — | — | — |
| Operating income | -$33.4M | -$36.6M | -$32.5M | -$22.5M | -$17.5M |
| Net income | -$33.6M | -$36.2M | $36.2M | $29.7M | $17.3M |
| Diluted EPS | — | — | — | -$101.16 | -$32.15 |
| Operating cash flow | -$93,638.00 | -$29.9M | -$29.3M | -$31.5M | -$21.3M |
| Free cash flow | -$99,360.00 | -$30.2M | -$29.7M | -$31.5M | -$21.3M |
| Gross margin | — | — | — | — | — |
| Operating margin | 17701.3% | -2491.6% | -668.7% | -501.0% | — |
| Net margin | 17813.9% | -2465.1% | 745.8% | 661.5% | — |
| Line item | Q4 '24 | Q1 '24 | Q2 '24 | Q3 '25 | Q4 '25 | Q3 '25 | Q2 '25 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $350,000.00 | $0.00 | — | $0.00 | — | $8.8M | $116,036.00 | $3.9M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$8.3M | -$7.8M | -$2.6M | -$4.8M | -$2.3M | $4.7M | -$7.3M | -$1.6M |
| Net income | $51.2M | -$7.8M | -$2.4M | -$4.8M | $32.4M | $4.7M | -$7.3M | -$1.4M |
| Diluted EPS | — | -$19.71 | -$5.92 | -$9.13 | $2.61 | $4.26 | -$2.86 | -$0.37 |
| Operating cash flow | -$6.5M | -$7.0M | -$4.8M | -$5.4M | -$4.1M | -$1.6M | -$4.8M | -$4.4M |
| Free cash flow | -$6.5M | — | — | -$5.4M | — | — | — | -$4.5M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -2383.4% | — | — | — | — | 52.8% | -6315.8% | -40.3% |
| Net margin | 14624.5% | — | — | — | — | 53.0% | -6260.0% | -36.5% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-15 | SPANA CARL· President and CEO | Tax withholding | 142 | $14.34 | $2,036.28 | filing |
| 2026-07-15 | SPANA CARL· President and CEO | Tax withholding | 119 | $11.72 | $1,394.68 | filing |
| 2026-07-15 | WILLS STEPHEN T· Executive VP and CFO/COO | Tax withholding | 94 | $14.34 | $1,347.96 | filing |
| 2026-07-15 | WILLS STEPHEN T· Executive VP and CFO/COO | Tax withholding | 79 | $11.72 | $925.88 | filing |
| 2026-07-15 | SPANA CARL· President and CEO | Tax withholding | 33 | $11.77 | $388.41 | filing |
| 2026-07-15 | WILLS STEPHEN T· Executive VP and CFO/COO | Tax withholding | 22 | $11.77 | $258.94 | filing |
| 2025-12-30 | SPANA CARL· President and CEO | Tax withholding | 143 | $21.38 | $3,057.34 | filing |
| 2025-12-30 | SPANA CARL· President and CEO | Tax withholding | 138 | $21.38 | $2,950.44 | filing |
| 2025-12-30 | WILLS STEPHEN T· Executive VP and CFO/COO | Tax withholding | 95 | $21.38 | $2,031.10 | filing |
| 2025-12-30 | WILLS STEPHEN T· Executive VP and CFO/COO | Tax withholding | 91 | $21.38 | $1,945.58 | filing |
| 2025-12-30 | SPANA CARL· President and CEO | Tax withholding | 40 | $21.38 | $855.20 | filing |
| 2025-12-30 | WILLS STEPHEN T· Executive VP and CFO/COO | Tax withholding | 26 | $21.38 | $555.88 | filing |
| 2025-12-24 | WILLS STEPHEN T· Executive VP and CFO/COO | Sale | 565 | $16.74 | $9,460.53 | filing |
| 2025-12-09 | WILLS STEPHEN T· Executive VP and CFO/COO | Award | 345 | $0.00 | $0.00 | filing |
| 2025-12-09 | WILLS STEPHEN T· Executive VP and CFO/COO | Award | 95 | $0.00 | $0.00 | filing |
| 2025-12-09 | WILLS STEPHEN T· Executive VP and CFO/COO | Award | 330 | $0.00 | $0.00 | filing |
| 2025-12-09 | SPANA CARL· President and CEO | Award | 110 | $0.00 | $0.00 | filing |
| 2025-12-09 | SPANA CARL· President and CEO | Award | 380 | $0.00 | $0.00 | filing |
| 2025-12-09 | SPANA CARL· President and CEO | Award | 395 | $0.00 | $0.00 | filing |
| 2025-12-09 | DUNTON ALAN W | Award | 1,000 | $0.00 | $0.00 | filing |
| 2025-12-09 | DUNTON ALAN W | Award | 1,000 | $0.00 | $0.00 | filing |
| 2025-12-09 | PRENDERGAST JOHN K A | Award | 1,300 | $0.00 | $0.00 | filing |
| 2025-12-09 | PRENDERGAST JOHN K A | Award | 1,300 | $0.00 | $0.00 | filing |
| 2025-11-14 | SPANA CARL· President and CEO | Tax withholding | 119 | $8.00 | $952.00 | filing |
| 2025-11-14 | SPANA CARL· President and CEO | Tax withholding | 142 | $5.50 | $781.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.